Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAPAS 1 pediatric HIV pharmacokinetics and adherence trial
ISRCTN31084535Phase 2Completed
- Sponsor
- Medical Research Council
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of stavudine + lamivudine + nevirapine and lamivudine + stavudine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Medical Research Council. Primary endpoints: Grade 3 or 4 nevirapine-related adverse events and Pharmacokinetic parameters of lamivudine, stavudine, and nevirapine. Started Dec 2005; status: completed.
02
Drugs
stavudine + lamivudine + nevirapinelamivudine + stavudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ISRCTN31084535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN31084535.